1 / 22

Improved Tablet  Focus on stability  Focus on reasonable production

G&H Meeting 18-20 February, 2003 Liverpool, UK WP 7 Pharmaceutics (Lichtwer Pharma). Objectives…. Improved Tablet  Focus on stability  Focus on reasonable production  Focus on packaging material High-End Tablet  Vision?! Study Medication  Focus on time line

scott
Download Presentation

Improved Tablet  Focus on stability  Focus on reasonable production

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. G&H Meeting 18-20 February, 2003 Liverpool, UK WP 7 Pharmaceutics (Lichtwer Pharma) • Objectives… Improved Tablet Focus on stability  Focus on reasonable production  Focus on packaging material High-End Tablet  Vision?! Study Medication  Focus on time line  Focus on GCP compliance

  2. Improved Tablet • Comparing… • Dragee (Market Standard) • 300 mg Garlic powder • Higher amounts of excipients • Coating time: up to 15 h • Total process time: up to 24 h • Novel film coated tablet • 300 mg Garlic powder • Less amounts of excipients (pre dried) • Coating time:  up to 5 h • Total process time: up to 14 h • Advantages of a film tablet… • Size (Compliance) • Costs for Excipients • Costs for Production (time)

  3. Improved stabile Tablet • Details on Stability Study • Full ICH-guideline compliance • Tests under GMP conditions with validated methods • Three production batches providing a minimum of 100.000 tablets per batch • Three different controlled climatic zones • Up to seven different packaging materials • PVC-, PVDC, COC-Aluminium blister • Two different kinds of Alu-Alu blisters • PE-, and glass bottles • Two different dosage forms • 100 mg and 300 mg Tablets • Estimated full costs for the study: 160 k€

  4. Improved Tablet Dragees (Commercial Products) 25°C/60% and 40°C/75% Commercial products are insufficient !!!

  5. Improved Tablet Comparison Powder/Dragees 25 °C / 60% r.h. Proof that commercial tablet formulations are sub optimal

  6. Improved Tablet • Comparing… Commercial Dragee vs. Novel Film Tablet • Dragee • 300 mg Garlic powder • 117 mg Lactose monohydrate • 9 mg Cellulose • 5 mg Silicium dioxide • 3 mg Mg Stearate • 224 mg Saccharose • 46 mg Talcum • 22 mg HPMC (mod. Cellulose) • 9 mg Castor oil, native • 5 mg Polyethylenglycol • 5 mg Polyvinylpyrrolidon • 2 mg Silicium dioxide • 2 mg Gelatine • 1 mg Montan glycol wax • 750 mg Total Weight • Novel film coated tablet • 300 mg Garlic powder • 117 mg microcristalline Cellulose • 24 mg Lactose, anhydrous • 10 mg Cellulose • 5 mg Silicium dioxide • 6 mg Soy polysaccharides • 3 mg Triglycerides • 25 mg HPMC (mod. Cellulose) • 5 mg Talcum • 4 mg Titan dioxide • 1 mg Carnauba wax • 500 mg Total Weight

  7. Improved Tablet Comparison Tablets with lyophilisised/non lyophilisised Powder/Dragees 25 °C / 60% r.h. Improvement of Stability of at least >100%

  8. Improved Tablet Comparison Packaging Material 25 °C / 60% r.h.

  9. Improved Tablet Comparison Packaging Material 30 °C / 70% r.h.

  10. Improved Tablet Comparison Packaging Material 40 °C / 75% r.h. • Conclusion • at least 24 months stability available • countries with difficult climatic conditions included!

  11. Improved Tablet Comparison Packaging Material 25 °C / 75% r.h. – 300 mg Tablets

  12. Improved Tablet Comparison Packaging Material 30 °C / 70% r.h. – 300 mg Tablets

  13. Improved Tablet Comparison Packaging Material 40 °C / 75% r.h. – 300 mg Tablets

  14. Improved Tablet Comparison Blister Material 25 °C / 60% r.h. – 300 mg Tablets

  15. Improved Tablet • Conclusion • Sugar coated tablets are not suitable to meet the high international standards of pharmaceutical stability • No kind of transparent polymer blister quality provide sufficient protection • A strict dry formulation (ingredients and process) combined with… • a 100% water vapour resistant packaging …are indispensable

  16. High-End Tablet • Garlic powder combined with a alliin rich extract • Laboratory experiments to gain a alliin enriched extract were successful • 4-5 fold enrichment of alliin (up to 7%in total) without transformation to allicin by an economic single-step extraction procedure • Extract seems to be suitable for direct use for production (“crystalline like” – not sticky) • Scale up experiments – still open

  17. High-End Tablet • Garlic powder combined with an alliin rich extract • Development of a slow release matrix tablet – open • Additional development time of 9-15 months is necessary (only with orientating stability data) • Realisation: not really realistic – see end of the project in Jan 2004!

  18. Study medication Human Intervention Study • Three arm study – double blind performing a double dummy design • Verum: Garlic powder tabletsReference: Statin medication (Cholesterol- Synthesis-InhibitorPlacebo: for Garlic tablets and for statin medication • 30 Volunteers in each group; 2100 mg garlic powder a day; Treatment over 100 days • Medication produced and packed under GMP

  19. Tablet core Gastric resistant film Sugar coating Improved Tablet • Formulation – Study medication • “Film-Dragee” • 300 mg Garlic powder • 187 mg Lactose anhydrous • 25 mg Cellulose • 4 mg Silicium dioxide • 4 mg Mg Stearate • ca. 40 mg Methacrylic acid copolymer • ca. 10 mg Citric acid • ca. 5 mg Talcum • 224 mg Saccharose • 46 mg Talcum • 5 mg Polyethylenglycol • 5 mg Polyvinylpyrrolidon • 2 mg Silicium dioxide • 2 mg Gelatine • 1 mg Montan glycol wax • Ca. 800 mg Total weight

  20. Study medication Human Intervention Study • Verum: Tablet design Gastric Fluid Resistant Coating Sugar Coating Tablet Core „Dragee“

  21. Study medication Time schedule • 7th-8th Week Production Verum & Placebo • 7th-8th Week Writing & Authorisation production protocol • 9th-10th Week Writing Randomisation Plan • 9th-10th Week Quality Control Verum & Placebo • 10th-11th Week Writing & Authorisation packaging/ labelling • 12th Week Packaging & Labelling • 13th-14th Week Final Release & Delivery

  22. Anybody who fell asleep? Thanks for listening!!! Fine!

More Related